<code id='AE5C5D2A8C'></code><style id='AE5C5D2A8C'></style>

<acronym id='AE5C5D2A8C'></acronym>

<center id='AE5C5D2A8C'><center id='AE5C5D2A8C'><tfoot id='AE5C5D2A8C'></tfoot></center><abbr id='AE5C5D2A8C'><dir id='AE5C5D2A8C'><tfoot id='AE5C5D2A8C'></tfoot><noframes id='AE5C5D2A8C'>

<optgroup id='AE5C5D2A8C'><strike id='AE5C5D2A8C'><sup id='AE5C5D2A8C'></sup></strike><code id='AE5C5D2A8C'></code></optgroup>

<b id='AE5C5D2A8C'><label id='AE5C5D2A8C'><select id='AE5C5D2A8C'><dt id='AE5C5D2A8C'><span id='AE5C5D2A8C'></span></dt></select></label></b><u id='AE5C5D2A8C'></u>

~~<i id='AE5C5D2A8C'><strike id='AE5C5D2A8C'><tt id='AE5C5D2A8C'><pre id='AE5C5D2A8C'></pre></tt></strike></i>~~

Home» leisure time» Wikipedia

Wikipedia

Wikipedia

author：leisure time 2025-09-27 17:09:20 Page View：1556

Johnson & Johnson sign — MARK RALSTON/AFP via Getty Images

WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.

J&J joins a flurry of litigation challenging the Medicare drug price negotiation program, which is set to start this fall. Merck, Bristol Myers Squibb, the brand-drug lobby PhRMA, and the U.S. Chamber of Commerce have also filed suit. The negotiated prices would go into effect in 2026.

advertisement

The company argued that it is entitled to sue because its blockbuster blood thinner drug Xarelto may be up for negotiation in the first round of ten drugs Medicare will examine, but that list is not set to be announced officially until Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： AbbVie dramatically boosts its spending on lobbying
Next article： Alkermes shareholders re

explore

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

AlexHogan/STATTocontainthespreadofCovid-19,Alaskaisplanningtotripleitsnumberofcontacttracers.Utahhas

Peter Hotez and the public health issue of online harassment

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

Providers still hesitate to prescribe buprenorphine, study finds

Anurseholdstabsofbuprenorphine.EliseAmendola/APSignificantchallengesremainbeforemostAmericanclinicia

read more